Reuters logo
BRIEF-Vifor Pharma: three outcomes trials in heart failure and iron deficiency
2017年7月12日 / 凌晨5点10分 / 4 个月前

BRIEF-Vifor Pharma: three outcomes trials in heart failure and iron deficiency

July 12 (Reuters) - VIFOR PHARMA AG:

* ANNOUNCES THREE OUTCOMES TRIALS IN HEART FAILURE AND IRON DEFICIENCY

* FURTHER ANALYSIS OF EXISTING DATA SUGGESTS FERINJECT MAY HAVE A POSITIVE IMPACT ON MORBIDITY AND MORTALITY IN PATIENTS WITH SYSTOLIC HEART FAILURE Source text - bit.ly/2uc8T0i Further company coverage: (Gdynia Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below